Zimmer Biomet Holdings, Inc. (NYSE:ZBH) dropped -0.47% and closed the trade at $ 124.30. The company recorded a trading capacity of 1.59 million shares above its three months average daily volume of 1.55 million shares. During the last trade, shares reached to high price of $124.98 and touched the low price of $123.53. The stock’s 50-day moving average is noted at $128.71 and its 200-day moving average is stands at $118.27.
Additionally, the company has a PE ratio of 113.52 and has EPS of 1.10. The company has market capitalization of $24.86B.
Currently Zimmer Biomet Holdings, Inc. (ZBH) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “18″ Analysts”. “1” rated “Sell” for the company. “6” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $139.65 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $155.00 however minimum price target advised by analysts is $95.00. The Median price target for the stock is measured at $145.00.
Presently, Analysts decided consensus EPS estimate of $1.79 for present quarter and one month ago projected EPS estimate was at $1.79. If we take a look at back 3 month ago, consensus EPS estimate was $1.82.
A current consensus EPS estimate for next quarter is at $2.16 and 3 month ago EPS forecast was $2.17. Have a look at back 1 month ago, consensus EPS forecast was seen at $2.16.
For current fiscal year, most recent EPS estimate is set at $7.97 based on Analyst consensus and three month ago consensus EPS opinions was at $7.96. During period one month ago, consensus EPS forecast was decided at $7.97.
A current consensus EPS projection for next fiscal year is observed at $8.81 and one month ago consensus EPS forecast was at $8.82. Take a look at back three month ago, consensus EPS estimate opinions was decided at $8.76 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 19 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 6 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 19 said a “Buy Rating” and 2 announced “Overweight Rating”. 9 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.